Verano Holdings (VRNO) Gross Margin (2021 - 2026)

Verano Holdings (VRNO) reported Gross Margin of 47.54% for Q1 2026, up 8.0% year-over-year from 44.02% in Q1 2025, and down 7.06% quarter-over-quarter from 51.16% in Q4 2025.

Verano Holdings (VRNO) Gross Margin (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Gross Margin data on file, last reported at 47.54% in Q1 2026.

  • Gross Margin for Q1 2026 came in at 47.54%, up 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 50.36% (up 71.0% YoY), and the FY2025 annual result was 50.33%, down 19.0% from the prior year.
  • Gross Margin declined to 47.54% in Q1 2026 per VRNO's latest filing, from 51.16% in the prior quarter.
  • Over five years, Gross Margin peaked at 13227.17% in Q1 2024 and troughed at 43.87% in Q2 2022.
  • A 5-year average of 824.82% and a median of 49.28% in 2024 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin surged 1317908 bps in 2024, then sank 1317970 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 45.74% in 2022, then gained by 8 bps to 49.59% in 2023, then dropped by 1 bps to 49.28% in 2024, then rose by 4 bps to 51.16% in 2025, then retreated by 7 bps to 47.54% in 2026.
  • Business Quant data shows VRNO's Gross Margin at 47.54% in Q1 2026, 51.16% in Q4 2025, and 46.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 49.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 71.66%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.26%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -293.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 65.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 61.20%
10 Verano Holdings - - 98.98 Mn 47.54%

Historic Data

Download Data
DateValue
Mar 31, 2026 47.54%
Dec 31, 2025 51.16%
Sep 30, 2025 46.96%
Jun 30, 2025 55.86%
Mar 31, 2025 47.46%
Dec 31, 2024 49.28%
Sep 30, 2024 50.35%
Jun 30, 2024 51.41%
Mar 31, 2024 13,227.17%
Dec 31, 2023 49.59%
Sep 30, 2023 55.49%
Jun 30, 2023 49.20%
Mar 31, 2023 48.09%
Dec 31, 2022 45.74%
Sep 30, 2022 54.04%
Jun 30, 2022 43.87%
Mar 31, 2022 48.76%
Dec 31, 2021 51.71%
Sep 30, 2021 47.56%
Jun 30, 2021 34.77%